Business Context and Reporting Period
This Form 8-K is filed by Cyclacel Pharmaceuticals, Inc. (CYCC) on August 29, 2024, regarding a notice of potential delisting from The Nasdaq Capital Market. The filing addresses a determination made by Nasdaq on August 26, 2024, concerning the company's compliance with listing standards.
Key Financial Metrics
The filing does not provide a comprehensive financial statement. The only specific financial metric disclosed is that the Company reported stockholders' equity of less than $2.5 million as of June 30, 2024. This figure triggered the non-compliance notice under Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"). Revenue, profit, cash flow, margins, debt, and liquidity figures are not provided in this document.
Material Changes and Events
- Delisting Notice: Nasdaq determined the Company was not in compliance with the Equity Rule due to insufficient stockholders' equity.
- Appeal Filed: The Company timely requested a hearing before a Nasdaq Hearings Panel to contest the delisting.
- Hearing Scheduled: A hearing is scheduled for October 15, 2024.
- Stay of Action: The request for a hearing automatically stays any suspension or delisting action pending the Panel's decision.
Outlook, Risks, and Management Commentary
Management intends to present a plan for regaining and sustaining compliance with the Equity Rule at the October 15 hearing. However, the filing explicitly states there can be no assurance that the hearing will be successful. Even if the Panel determines to continue the listing, there is no guarantee the Company will satisfy continued listing criteria subsequently. If the appeal is denied or compliance is not regained during any additional period granted, the Company's common stock will be subject to delisting from Nasdaq.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel scheduled for October 15, 2024.
- Review the Company's specific plan for regaining compliance with the $2.5 million stockholders' equity requirement.
- Monitor subsequent filings for any updates on the Company's stockholders' equity position.
- Check if the Company's securities are suspended or delisted if the appeal is unsuccessful.